News & Events about Revance Therapeutics Inc.
Business Wire
2 months ago
Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced that the company will participate in the 34th Annual Piper Sandler Healthcare Conference, taking place November 29-December 1, 2022, in New York City. Chief...
One in Five Americans Who Have Been Infected With the Virus Said to Have Long COVID One in Five Americans Who Have Been Infected With the Virus Said to Have Long COVID PR Newswire PALM BEACH, Fla., Nov. 17, 2022 FinancialNewsMedia.com News Commentary - Since the beginning of the pandemic...
Business Wire
2 months ago
Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced that the company will participate in the Stifel 2022 Healthcare Conference, taking place November 15-16, 2022, in New York City. Chief Financial Officer...
Business Wire
3 months ago
Revance Therapeutics, Inc. (Nasdaq: RVNC), a commercial-stage biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced the publication of two peer-reviewed articles in the Aesthetic Surgery Journal, the official journal of The Aesthetic Society. The...
Business Wire
3 months ago
Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, announced today it will present two video abstracts featuring DAXXIFY (DaxibotulinumtoxinA-lanm) for injection at the American Society for Dermatologic Surgery (ASDS) Annual...